CorMedix Inc.
CRMD
$8.65
$0.111.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.92% | 23.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.92% | 23.34% | |||
| Cost of Revenue | 7.50% | 47.60% | |||
| Gross Profit | -1.72% | 21.44% | |||
| SG&A Expenses | 16.58% | -19.80% | |||
| Depreciation & Amortization | 1.58% | 179.44% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.56% | 12.02% | |||
| Operating Income | -8.18% | 35.02% | |||
| Income Before Tax | -1.42% | 7.36% | |||
| Income Tax Expenses | -59.83% | 175.78% | |||
| Earnings from Continuing Operations | 175.33% | -87.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 175.33% | -87.09% | |||
| EBIT | -8.18% | 35.02% | |||
| EBITDA | -6.97% | 44.66% | |||
| EPS Basic | 193.71% | -88.44% | |||
| Normalized Basic EPS | -8.20% | 27.09% | |||
| EPS Diluted | 172.87% | -87.54% | |||
| Normalized Diluted EPS | -6.50% | 21.16% | |||
| Average Basic Shares Outstanding | 0.85% | 3.83% | |||
| Average Diluted Shares Outstanding | -0.99% | 8.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||